Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2005;90(Supplement 1):i26-i29; doi:10.1136/adc.2004.059386
Copyright © 2005 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Archives of Disease in Childhood 2005;90:i26-i29
© 2005 BMJ Publishing Group & Royal College of Paediatrics and Child Health

Article

Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder

J Barton

Correspondence to:
Correspondence to:
Dr J Barton
North Staffordshire Combined Health Care NHS Trust, Moorlands Team, Abbey Hulton Clinic, Leek Road, Stoke-On-Trent, Staffordshire ST2 8BP, UK; Joanne.Barton{at}nsch-tr.wmids.nhs.uk

ABSTRACT

Atomoxetine is a novel, non-stimulant, highly selective noradrenaline reuptake inhibitor that has been studied for use in the treatment of attention deficit/hyperactivity disorder (ADHD). Data from clinical trials show it to be well tolerated and effective in the treatment of ADHD in children, adolescents, and adults. Improvements were seen not only in core symptoms of ADHD, but also in broader social and family functioning and self esteem. Once-daily dosing of atomoxetine has been shown to be effective in providing continuous symptom relief. Atomoxetine does not appear to have abuse potential and is associated with a benign side effect profile. The development of atomoxetine thus represents an important advance in the pharmacological management of ADHD.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Introduction
P Hill
Arch. Dis. Child. 2005 90: i1. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Ashton, H., Gallagher, P., Moore, B. (2006). The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. J Psychopharmacol 20: 602-610 [Abstract]  

eLetters:

Read all eLetters

What about the cost?
Mike Farrall
ADC Online, 31 Jan 2005 [Full text]
True status of supplement not made clear to reader
Charlotte M Wright, et al.
ADC Online, 22 Apr 2005 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs